{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:30:27Z","timestamp":1761895827702,"version":"3.40.3"},"publisher-location":"Dordrecht","reference-count":137,"publisher":"Springer Netherlands","isbn-type":[{"type":"print","value":"9789400778924"},{"type":"electronic","value":"9789400778931"}],"license":[{"start":{"date-parts":[[2013,12,14]],"date-time":"2013-12-14T00:00:00Z","timestamp":1386979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2013,12,14]],"date-time":"2013-12-14T00:00:00Z","timestamp":1386979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014]]},"DOI":"10.1007\/978-94-007-7893-1_6","type":"book-chapter","created":{"date-parts":[[2014,1,17]],"date-time":"2014-01-17T10:51:16Z","timestamp":1389955876000},"page":"77-94","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Clinical, Diagnostic, and Therapeutic Aspects of the Marfan Syndrome"],"prefix":"10.1007","author":[{"given":"Jason R.","family":"Cook","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,12,14]]},"reference":[{"key":"6_CR1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1146\/annurev.med.51.1.481","volume":"51","author":"RE Pyeritz","year":"2000","unstructured":"Pyeritz RE (2000) The Marfan syndrome. Annu Rev Med 51:481\u2013510","journal-title":"Annu Rev Med"},{"key":"6_CR2","first-page":"220","volume":"13","author":"A Marfan","year":"1896","unstructured":"Marfan A (1896) Un cas de d\u00e9formation cong\u00e9nitale des quatre membres plus pronoc\u00e9e aux extr\u00e9mites charact\u00e9ris\u00e9e par l\u2019allongement des os avec uncertain degr\u00e9d\u2019amincissement. Bull Mem Soc Med Hop 13:220\u2013226","journal-title":"Bull Mem Soc Med Hop"},{"key":"6_CR3","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0021-9681(55)90192-2","volume":"2","author":"VA McKusick","year":"1955","unstructured":"McKusick VA (1955) Heritable disorders of connective tissue. III. The Marfan syndrome. J Chronic Dis 2:609\u2013644","journal-title":"J Chronic Dis"},{"key":"6_CR4","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/352337a0","volume":"352","author":"HC Dietz","year":"1991","unstructured":"Dietz HC, Cutting CG, Pyeritz RE, Maslen CL, Sakai LY, Corson GM, Puffenberger EG, Hamosh A, Nanthakumar EJ, Curristin SM, Stetten G, Meyers D, Francomano Clair A (1991) Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 352:337\u2013339","journal-title":"Nature"},{"key":"6_CR5","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/352330a0","volume":"352","author":"B Lee","year":"1991","unstructured":"Lee B, Godfrey M, Vitale E, Hori H, Mattei M-G, Sarfarazi M, Tsipouras P, Ramirez F, Hollister D (1991) Linkage of Marfan syndrome and a phenotypically related disorder are linked to two different fibrillin genes. Nature 352:330\u2013334","journal-title":"Nature"},{"key":"6_CR6","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.2106\/JBJS.I.00892","volume":"92","author":"PD Sponseller","year":"2010","unstructured":"Sponseller PD, Erkula G, Skolasky RL, Venuti KD, Dietz HC (2010) Improving clinical recognition of Marfan syndrome. J Bone Joint Surg Am 92:1868\u20131875","journal-title":"J Bone Joint Surg Am"},{"key":"6_CR7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/heart.88.1.97","volume":"88","author":"JC Dean","year":"2002","unstructured":"Dean JC (2002) Management of Marfan syndrome. Heart 88:97\u2013103","journal-title":"Heart"},{"key":"6_CR8","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJM199904293401702","volume":"340","author":"VL Gott","year":"1999","unstructured":"Gott VL, Greene PS, Alejo DE, Cameron DE, Naftel DC, Miller DC, Gillinov AM, Laschinger JC, Pyeritz RE (1999) Replacement of the aortic root in patients with Marfan\u2019s syndrome. N Engl J Med 340:1307\u20131313","journal-title":"N Engl J Med"},{"key":"6_CR9","first-page":"1","volume":"17","author":"F Ramirez","year":"2007","unstructured":"Ramirez F, Dietz H (2007) Marfan syndrome: from molecular pathogenesis to clinical treatment. Curr Opin Genet Dev 17:1\u20137","journal-title":"Curr Opin Genet Dev"},{"key":"6_CR10","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/0002-9149(90)90979-B","volume":"65","author":"T Geva","year":"1990","unstructured":"Geva T, Sanders SP, Diogenes MS, Rockenmacher S, Van Praagh R (1990) Two-dimensional and Doppler echocardiographic and pathologic characteristics of the infantile Marfan syndrome. Am J Cardiol 65:1230\u20131237","journal-title":"Am J Cardiol"},{"key":"6_CR11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/jmg.28.4.267","volume":"28","author":"IM Buntinx","year":"1991","unstructured":"Buntinx IM, Willems PJ, Spitaels SE, Van Reempst PJ, De Paepe AM, Dumon JE (1991) Neonatal Marfan syndrome with congenital arachnodactyly, flexion contractures, and severe cardiac valve insufficiency. J Med Genet 28:267\u2013273","journal-title":"J Med Genet"},{"key":"6_CR12","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1651-2227.1999.tb01277.x","volume":"88","author":"D Bresters","year":"1999","unstructured":"Bresters D, Nikkels PG, Meijboom EJ, Hoorntje TM, Pals G, Beemer FA (1999) Clinical, pathological and molecular genetic findings in a case of neonatal Marfan syndrome. Acta Paediatr 88:98\u2013101","journal-title":"Acta Paediatr"},{"key":"6_CR13","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.amjcard.2004.11.042","volume":"95","author":"LJ Meijboom","year":"2005","unstructured":"Meijboom LJ, Timmermans J, van Tintelen JP, Nollen GJ, De Backer J, van den Berg MP, Boers GH, Mulder BJ (2005) Evaluation of left ventricular dimensions and function in Marfan\u2019s syndrome without significant valvular regurgitation. Am J Cardiol 95:795\u2013797","journal-title":"Am J Cardiol"},{"key":"6_CR14","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ijcard.2005.10.010","volume":"112","author":"JF De Backer","year":"2006","unstructured":"De Backer JF, Devos D, Segers P, Matthys D, Francois K, Gillebert TC, De Paepe AM, De Sutter J (2006) Primary impairment of left ventricular function in Marfan syndrome. Int J Cardiol 112:353\u2013358","journal-title":"Int J Cardiol"},{"key":"6_CR15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0002-9149(00)80066-1","volume":"75","author":"DI Silverman","year":"1995","unstructured":"Silverman DI, Burton KJ, Gray J, Bosner MS, Kouchoukos NT, Roman MJ, Boxer M, Devereux RB, Tsipouras P (1995) Life expectancy in the Marfan syndrome. Am J Cardiol 75:157\u2013160","journal-title":"Am J Cardiol"},{"key":"6_CR16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/adc.84.2.129","volume":"84","author":"CD van Karnebeek","year":"2001","unstructured":"van Karnebeek CD, Naeff MS, Mulder BJ, Hennekam RC, Offringa M (2001) Natural history of cardiovascular manifestations in Marfan syndrome. Arch Dis Child 84:129\u2013137","journal-title":"Arch Dis Child"},{"key":"6_CR17","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1136\/hrt.2008.152934","volume":"95","author":"A Kiotsekoglou","year":"2009","unstructured":"Kiotsekoglou A, Sutherland GR, Moggridge JC, Nassiri DK, Camm AJ, Child AH (2009) The unravelling of primary myocardial impairment in Marfan syndrome by modern echocardiography. Heart 95:1561\u20131566","journal-title":"Heart"},{"key":"6_CR18","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1046\/j.1469-0705.2002.00764.x","volume":"20","author":"GR DeVore","year":"2002","unstructured":"DeVore GR (2002) First-trimester fetal echocardiography: is the future now? Ultrasound Obstet Gynecol 20:6\u20138","journal-title":"Ultrasound Obstet Gynecol"},{"key":"6_CR19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/uog.4011","volume":"30","author":"R Stadie","year":"2007","unstructured":"Stadie R, Geipel A, Heep A, Herberg U, Welker B, Gembruch U, Berg C (2007) Prenatal diagnosis of Marfan syndrome. Ultrasound Obstet Gynecol 30:119\u2013121","journal-title":"Ultrasound Obstet Gynecol"},{"key":"6_CR20","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/pd.1482","volume":"26","author":"KR Lopes","year":"2006","unstructured":"Lopes KR, Delezoide AL, Baumann C, Vuillard E, Luton D, Chitrit Y, Azancot A (2006) Prenatal Marfan syndrome: report of one case and review of the literature. Prenat Diagn 26:696\u2013699","journal-title":"Prenat Diagn"},{"key":"6_CR21","first-page":"1179","volume":"141","author":"T Geva","year":"1987","unstructured":"Geva T, Hegesh J, Frand M (1987) The clinical course and echocardiographic features of Marfan\u2019s syndrome in childhood. Am J Dis Child 141:1179\u20131182","journal-title":"Am J Dis Child"},{"issue":"Suppl 1","key":"6_CR22","first-page":"II329","volume":"108","author":"M Nataatmadja","year":"2003","unstructured":"Nataatmadja M, West M, West J, Summers K, Walker P, Nagata M, Watanabe T (2003) Abnormal extracellular matrix protein transport associated with increased apoptosis of vascular smooth muscle cells in Marfan syndrome and bicuspid aortic valve thoracic aortic aneurysm. Circulation 108(Suppl 1):II329\u2013II334","journal-title":"Circulation"},{"key":"6_CR23","doi-asserted-by":"crossref","first-page":"I282","DOI":"10.1161\/hc37t1.094856","volume":"104","author":"H Nagashima","year":"2001","unstructured":"Nagashima H, Sakomura Y, Aoka Y, Uto K, Kameyama K, Ogawa M, Aomi S, Koyanagi H, Ishizuka N, Naruse M, Kawana M, Kasanuki H (2001) Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis in cystic medial degeneration associated with Marfan\u2019s syndrome. Circulation 104:I282\u2013I287","journal-title":"Circulation"},{"key":"6_CR24","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1161\/01.CIR.103.3.393","volume":"103","author":"K Niwa","year":"2001","unstructured":"Niwa K, Perloff JK, Bhuta SM, Laks H, Drinkwater DC, Child JS, Miner PD (2001) Structural abnormalities of great arterial walls in congenital heart disease: light and electron microscopic analyses. Circulation 103:393\u2013400","journal-title":"Circulation"},{"key":"6_CR25","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s10554-011-9867-5","volume":"27","author":"GH Sohn","year":"2011","unstructured":"Sohn GH, Jang SY, Moon JR, Yang JH, Sung K, Ki CS, Oh JK, Choe YH, Kim DK (2011) The usefulness of multidetector computed tomographic angiography for the diagnosis of Marfan syndrome by Ghent criteria. Int J Cardiovasc Imaging 27:679\u2013688","journal-title":"Int J Cardiovasc Imaging"},{"key":"6_CR26","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/heart.87.5.470","volume":"87","author":"GJ Nollen","year":"2002","unstructured":"Nollen GJ, van Schijndel KE, Timmermans J, Groenink M, Barentsz JO, van der Wall EE, Stoker J, Mulder BJ (2002) Pulmonary artery root dilatation in Marfan syndrome: quantitative assessment of an unknown criterion. Heart 87:470\u2013471","journal-title":"Heart"},{"key":"6_CR27","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1378\/chest.91.3.408","volume":"91","author":"EA Streeten","year":"1987","unstructured":"Streeten EA, Murphy EA, Pyeritz RE (1987) Pulmonary function in the Marfan syndrome. Chest 91:408\u2013412","journal-title":"Chest"},{"key":"6_CR28","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/jmg.2009.072785","volume":"47","author":"BL Loeys","year":"2010","unstructured":"Loeys BL, Dietz HC, Braverman AC, Callewaert BL, De Backer J, Devereux RB, Hilhorst-Hofstee Y, Jondeau G, Faivre L, Milewicz DM, Pyeritz RE, Sponseller PD, Wordsworth P, De Paepe AM (2010) The revised Ghent nosology for the Marfan syndrome. J Med Genet 47:476\u2013485","journal-title":"J Med Genet"},{"key":"6_CR29","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1161\/01.CIR.0000155243.70456.F4","volume":"111","author":"DM Milewicz","year":"2005","unstructured":"Milewicz DM, Dietz HC, Miller DC (2005) Treatment of aortic disease in patients with Marfan syndrome. Circulation 111:e150\u2013e157","journal-title":"Circulation"},{"key":"6_CR30","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1136\/hrt.2005.081638","volume":"92","author":"PM Engelfriet","year":"2006","unstructured":"Engelfriet PM, Boersma E, Tijssen JG, Bouma BJ, Mulder BJ (2006) Beyond the root: dilatation of the distal aorta in Marfan\u2019s syndrome. Heart 92:1238\u20131243","journal-title":"Heart"},{"key":"6_CR31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/oxfordjournals.epirev.a017997","volume":"21","author":"JF Blanchard","year":"1999","unstructured":"Blanchard JF (1999) Epidemiology of abdominal aortic aneurysms. Epidemiol Rev 21:207\u2013221","journal-title":"Epidemiol Rev"},{"key":"6_CR32","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.jvs.2011.02.065","volume":"54","author":"GA Antoniou","year":"2011","unstructured":"Antoniou GA, Georgiadis GS, Antoniou SA, Granderath FA, Giannoukas AD, Lazarides MK (2011) Abdominal aortic aneurysm and abdominal wall hernia as manifestations of a connective tissue disorder. J Vasc Surg 54:1175\u20131181","journal-title":"J Vasc Surg"},{"key":"6_CR33","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ejvs.2005.03.009","volume":"30","author":"E Choke","year":"2005","unstructured":"Choke E, Cockerill G, Wilson WR, Sayed S, Dawson J, Loftus I, Thompson MM (2005) A review of biological factors implicated in abdominal aortic aneurysm rupture. Eur J Vasc Endovasc Surg 30:227\u2013244","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"6_CR34","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1172\/JCI0215334","volume":"110","author":"GM Longo","year":"2002","unstructured":"Longo GM, Xiong W, Greiner TC, Zhao Y, Fiotti N, Baxter BT (2002) Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest 110:625\u2013632","journal-title":"J Clin Invest"},{"key":"6_CR35","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s00109-007-0213-2","volume":"85","author":"H Aoki","year":"2007","unstructured":"Aoki H, Yoshimura K, Matsuzaki M (2007) Turning back the clock: regression of abdominal aortic aneurysms via pharmacotherapy. J Mol Med (Berl) 85:1077\u20131088","journal-title":"J Mol Med (Berl)"},{"key":"6_CR36","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jbiomech.2011.11.021","volume":"45","author":"JD Humphrey","year":"2012","unstructured":"Humphrey JD, Holzapfel GA (2012) Mechanics, mechanobiology, and modeling of human abdominal aorta and aneurysms. J Biomech 45:805\u2013814","journal-title":"J Biomech"},{"key":"6_CR37","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1001\/archinte.161.20.2447","volume":"161","author":"B Loeys","year":"2001","unstructured":"Loeys B, Nuytinck L, Delvaux I, De Bie S, De Paepe A (2001) Genotype and phenotype analysis of 171 patients referred for molecular study of the fibrillin-1 gene FBN1 because of suspected Marfan syndrome. Arch Intern Med 161:2447\u20132454","journal-title":"Arch Intern Med"},{"key":"6_CR38","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.ejcts.2007.02.027","volume":"31","author":"S Waldmuller","year":"2007","unstructured":"Waldmuller S, Muller M, Warnecke H, Rees W, Schols W, Walterbusch G, Ennker J, Scheffold T (2007) Genetic testing in patients with aortic aneurysms\/dissections: a novel genotype\/phenotype correlation? Eur J Cardiothorac Surg 31:970\u2013975","journal-title":"Eur J Cardiothorac Surg"},{"key":"6_CR39","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1161\/01.CIR.52.4.651","volume":"52","author":"OR Brown","year":"1975","unstructured":"Brown OR, DeMots H, Kloster FE, Roberts A, Menashe VD, Beals RK (1975) Aortic root dilatation and mitral valve prolapse in Marfan\u2019s syndrome: an ECHOCARDIOgraphic study. Circulation 52:651\u2013657","journal-title":"Circulation"},{"key":"6_CR40","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/0002-9343(83)91070-7","volume":"74","author":"RE Pyeritz","year":"1983","unstructured":"Pyeritz RE, Wappel MA (1983) Mitral valve dysfunction in the Marfan syndrome. Clinical and echocardiographic study of prevalence and natural history. Am J Med 74:797\u2013807","journal-title":"Am J Med"},{"key":"6_CR41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199907013410101","volume":"341","author":"LA Freed","year":"1999","unstructured":"Freed LA, Levy D, Levine RA, Larson MG, Evans JC, Fuller DL, Lehman B, Benjamin EJ (1999) Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med 341:1\u20137","journal-title":"N Engl J Med"},{"key":"6_CR42","first-page":"888","volume":"86","author":"RP Morse","year":"1990","unstructured":"Morse RP, Rockenmacher S, Pyeritz RE, Sanders SP, Bieber FR, Lin A, MacLeod P, Hall B, Graham JM Jr (1990) Diagnosis and management of infantile Marfan syndrome. Pediatrics 86:888\u2013895","journal-title":"Pediatrics"},{"key":"6_CR43","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0002-9149(83)90138-8","volume":"52","author":"HE Sisk","year":"1983","unstructured":"Sisk HE, Zahka KG, Pyeritz RE (1983) The Marfan syndrome in early childhood: analysis of 15 patients diagnosed at less than 4 years of age. Am J Cardiol 52:353\u2013358","journal-title":"Am J Cardiol"},{"key":"6_CR44","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1440-1754.1999.00355.x","volume":"35","author":"DK Ng","year":"1999","unstructured":"Ng DK, Chau KW, Black C, Thomas TM, Mak KL, Boxer M (1999) Neonatal Marfan syndrome: a case report. J Paediatr Child Health 35:321\u2013323","journal-title":"J Paediatr Child Health"},{"key":"6_CR45","doi-asserted-by":"crossref","first-page":"S1050","DOI":"10.1016\/S0003-4975(01)02974-5","volume":"72","author":"P Schroeyers","year":"2001","unstructured":"Schroeyers P, Wellens F, De Geest R, Degrieck I, Van Praet F, Vermeulen Y, Vanermen H (2001) Minimally invasive video-assisted mitral valve surgery: our lessons after a 4-year experience. Ann Thorac Surg 72:S1050\u2013S1054","journal-title":"Ann Thorac Surg"},{"key":"6_CR46","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1536\/ihj.26.1043","volume":"26","author":"Y Fujiseki","year":"1985","unstructured":"Fujiseki Y, Okuno K, Tanaka M, Shimada M, Takahashi M, Kawanishi K (1985) Myocardial involvement in the Marfan syndrome. Jpn Heart J 26:1043\u20131050","journal-title":"Jpn Heart J"},{"key":"6_CR47","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/clc.3","volume":"30","author":"M Rybczynski","year":"2007","unstructured":"Rybczynski M, Koschyk DH, Aydin MA, Robinson PN, Brinken T, Franzen O, Berger J, Hofmann T, Meinertz T, von Kodolitsch Y (2007) Tissue Doppler imaging identifies myocardial dysfunction in adults with Marfan syndrome. Clin Cardiol 30:19\u201324","journal-title":"Clin Cardiol"},{"key":"6_CR48","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/ejechocard\/jen003","volume":"9","author":"A Kiotsekoglou","year":"2008","unstructured":"Kiotsekoglou A, Bajpai A, Bijnens BH, Kapetanakis V, Athanassopoulos G, Moggridge JC, Mullen MJ, Nassiri DK, Camm J, Sutherland GR, Child AH (2008) Early impairment of left ventricular long-axis systolic function demonstrated by reduced atrioventricular plane displacement in patients with Marfan syndrome. Eur J Echocardiogr 9:605\u2013613","journal-title":"Eur J Echocardiogr"},{"key":"6_CR49","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0735-1097(02)02699-2","volume":"41","author":"AT Yetman","year":"2003","unstructured":"Yetman AT, Bornemeier RA, McCrindle BW (2003) Long-term outcome in patients with Marfan syndrome: is aortic dissection the only cause of sudden death? J Am Coll Cardiol 41:329\u2013332","journal-title":"J Am Coll Cardiol"},{"key":"6_CR50","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/eurjhf\/hfq127","volume":"12","author":"F Alpendurada","year":"2010","unstructured":"Alpendurada F, Wong J, Kiotsekoglou A, Banya W, Child A, Prasad SK, Pennell DJ, Mohiaddin RH (2010) Evidence for Marfan cardiomyopathy. Eur J Heart Fail 12:1085\u20131091","journal-title":"Eur J Heart Fail"},{"key":"6_CR51","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.2169\/internalmedicine.49.3880","volume":"49","author":"G Kahveci","year":"2010","unstructured":"Kahveci G, Erkol A, Yilmaz F (2010) Dilated cardiomyopathy in a patient with Marfan syndrome accompanied by chronic type A aortic dissection and right atrial thrombus. Intern Med 49:2583\u20132586","journal-title":"Intern Med"},{"key":"6_CR52","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0002-9149(94)90405-7","volume":"74","author":"RW Jeremy","year":"1994","unstructured":"Jeremy RW, Huang H, Hwa J, McCarron H, Hughes CF, Richards JG (1994) Relation between age, arterial distensibility, and aortic dilatation in the Marfan syndrome. Am J Cardiol 74:369\u2013373","journal-title":"Am J Cardiol"},{"key":"6_CR53","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/rheumatology\/34.2.126","volume":"34","author":"R Grahame","year":"1995","unstructured":"Grahame R, Pyeritz RE (1995) The Marfan syndrome: joint and skin manifestations are prevalent and correlated. Br J Rheumatol 34:126\u2013131","journal-title":"Br J Rheumatol"},{"key":"6_CR54","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00330-011-2073-y","volume":"21","author":"R Lundby","year":"2011","unstructured":"Lundby R, Kirkhus E, Rand-Hendriksen S, Hald J, Pripp AH, Smith HJ (2011) CT of the hips in the investigation of protrusion acetabuli in Marfan syndrome. A case control study. Eur Radiol 21:1485\u20131491","journal-title":"Eur Radiol"},{"key":"6_CR55","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/rheumatology\/40.3.358","volume":"40","author":"JM Le Parc","year":"2001","unstructured":"Le Parc JM, Molcard S, Tubach F (2001) Bone mineral density in Marfan syndrome. Rheumatology (Oxford) 40:358\u2013359","journal-title":"Rheumatology (Oxford)"},{"key":"6_CR56","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00198-003-1433-0","volume":"14","author":"PF Giampietro","year":"2003","unstructured":"Giampietro PF, Peterson M, Schneider R, Davis JG, Raggio C, Myers E, Burke SW, Boachie-Adjei O, Mueller CM (2003) Assessment of bone mineral density in adults and children with Marfan syndrome. Osteoporos Int 14:559\u2013563","journal-title":"Osteoporos Int"},{"key":"6_CR57","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/S0140-6736(98)12448-0","volume":"354","author":"R Fattori","year":"1999","unstructured":"Fattori R, Nienaber CA, Descovich B, Ambrosetto P, Reggiani LB, Pepe G, Kaufmann U, Negrini E, von Kodolitsch Y, Gensini GF (1999) Importance of dural ectasia in phenotypic assessment of Marfan\u2019s syndrome. Lancet 354:910\u2013913","journal-title":"Lancet"},{"key":"6_CR58","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00125817-200005000-00003","volume":"2","author":"NU Ahn","year":"2000","unstructured":"Ahn NU, Sponseller PD, Ahn UM, Nallamshetty L, Rose PS, Buchowski JM, Garrett ES, Kuszyk BS, Fishman EK, Zinreich SJ (2000) Dural ectasia in the Marfan syndrome: MR and CT findings and criteria. Genet Med 2:173\u2013179","journal-title":"Genet Med"},{"key":"6_CR59","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1097\/00007632-200009150-00013","volume":"25","author":"PD Sponseller","year":"2000","unstructured":"Sponseller PD, Bhimani M, Solacoff D, Dormans JP (2000) Results of brace treatment of scoliosis in Marfan syndrome. Spine 25:2350\u20132354","journal-title":"Spine"},{"key":"6_CR60","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2106\/00004623-199506000-00007","volume":"77","author":"PD Sponseller","year":"1995","unstructured":"Sponseller PD, Hobbs W, Riley LH 3rd, Pyeritz RE (1995) The thoracolumbar spine in Marfan syndrome. J Bone Joint Surg Am 77:867\u2013876","journal-title":"J Bone Joint Surg Am"},{"key":"6_CR61","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/BF01959393","volume":"149","author":"U Vetter","year":"1990","unstructured":"Vetter U, Mayerhofer R, Lang D, von Bernuth G, Ranke MB, Schmaltz AA (1990) The Marfan syndrome \u2013 analysis of growth and cardiovascular manifestation. Eur J Pediatr 149:452\u2013456","journal-title":"Eur J Pediatr"},{"key":"6_CR62","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/jor.20314","volume":"25","author":"KB Jones","year":"2007","unstructured":"Jones KB, Sponseller PD, Erkula G, Sakai L, Ramirez F, Dietz HC 3rd, Kost-Byerly S, Bridwell KH, Sandell L (2007) Symposium on the musculoskeletal aspects of Marfan syndrome: meeting report and state of the science. J Orthop Res 25:413\u2013422","journal-title":"J Orthop Res"},{"key":"6_CR63","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1002\/ajmg.a.34245","volume":"155A","author":"N Zadeh","year":"2011","unstructured":"Zadeh N, Bernstein JA, Niemi AK, Dugan S, Kwan A, Liang D, Hyland JC, Hoyme HE, Hudgins L, Manning MA (2011) Ectopia lentis as the presenting and primary feature in Marfan syndrome. Am J Med Genet A 155A:2661\u20132668","journal-title":"Am J Med Genet A"},{"key":"6_CR64","first-page":"179","volume":"10","author":"Y Nahum","year":"2008","unstructured":"Nahum Y, Spierer A (2008) Ocular features of Marfan syndrome: diagnosis and management. Isr Med Assoc J 10:179\u2013181","journal-title":"Isr Med Assoc J"},{"key":"6_CR65","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.survophthal.2006.08.008","volume":"51","author":"AY Nemet","year":"2006","unstructured":"Nemet AY, Assia EI, Apple DJ, Barequet IS (2006) Current concepts of ocular manifestations in Marfan syndrome. Surv Ophthalmol 51:561\u2013575","journal-title":"Surv Ophthalmol"},{"key":"6_CR66","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO;2-R","volume":"62","author":"A De Paepe","year":"1996","unstructured":"De Paepe A, Devereux RB, Dietz HC, Hennekam RC, Pyeritz RE (1996) Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 62:417\u2013426","journal-title":"Am J Med Genet"},{"key":"6_CR67","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00006982-200302000-00004","volume":"23","author":"SY Lee","year":"2003","unstructured":"Lee SY, Ang CL (2003) Results of retinal detachment surgery in Marfan syndrome in Asians. Retina 23:24\u201329","journal-title":"Retina"},{"key":"6_CR68","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00006982-200208000-00005","volume":"22","author":"T Sharma","year":"2002","unstructured":"Sharma T, Gopal L, Shanmugam MP, Bhende PS, Agrawal R, Shetty NS, Gopalakrishna M, Rao MK, Balusamy S (2002) Retinal detachment in Marfan syndrome: clinical characteristics and surgical outcome. Retina 22:423\u2013428","journal-title":"Retina"},{"key":"6_CR69","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00005382-199203000-00008","volume":"7","author":"LT Tanoue","year":"1992","unstructured":"Tanoue LT (1992) Pulmonary involvement in collagen vascular disease: a review of the pulmonary manifestations of the Marfan syndrome, ankylosing spondylitis, Sjogren\u2019s syndrome, and relapsing polychondritis. J Thorac Imaging 7:62\u201377","journal-title":"J Thorac Imaging"},{"key":"6_CR70","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0003-4975(10)61142-3","volume":"37","author":"JR Hall","year":"1984","unstructured":"Hall JR, Pyeritz RE, Dudgeon DL, Haller JA Jr (1984) Pneumothorax in the Marfan syndrome: prevalence and therapy. Ann Thorac Surg 37:500\u2013504","journal-title":"Ann Thorac Surg"},{"key":"6_CR71","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/thx.39.10.780","volume":"39","author":"JR Wood","year":"1984","unstructured":"Wood JR, Bellamy D, Child AH, Citron KM (1984) Pulmonary disease in patients with Marfan syndrome. Thorax 39:780\u2013784","journal-title":"Thorax"},{"key":"6_CR72","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.7326\/0003-4819-62-6-1285","volume":"62","author":"EM Dwyer Jr","year":"1965","unstructured":"Dwyer EM Jr, Troncale F (1965) Spontaneous pneumothorax and pulmonary disease in the Marfan syndrome. Report of two cases and review of the literature. Ann Intern Med 62:1285\u20131292","journal-title":"Ann Intern Med"},{"key":"6_CR73","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000322958","volume":"82","author":"C Karpman","year":"2011","unstructured":"Karpman C, Aughenbaugh GL, Ryu JH (2011) Pneumothorax and bullae in Marfan syndrome. Respiration 82:219\u2013224","journal-title":"Respiration"},{"key":"6_CR74","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1399-0004.2010.01367.x","volume":"78","author":"GF Cipriano","year":"2010","unstructured":"Cipriano GF, Peres PA, Cipriano G Jr, Arena R, Carvalho AC (2010) Safety and cardiovascular behavior during pulmonary function in patients with Marfan syndrome. Clin Genet 78:57\u201365","journal-title":"Clin Genet"},{"key":"6_CR75","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jaad.2010.01.032","volume":"64","author":"M Ledoux","year":"2011","unstructured":"Ledoux M, Beauchet A, Fermanian C, Boileau C, Jondeau G, Saiag P (2011) A case-control study of cutaneous signs in adult patients with Marfan disease: diagnostic value of striae. J Am Acad Dermatol 64:290\u2013295","journal-title":"J Am Acad Dermatol"},{"key":"6_CR76","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(05)67789-6","volume":"366","author":"DP Judge","year":"2005","unstructured":"Judge DP, Dietz H (2005) Marfan\u2019s syndrome. Lancet 366:1965\u20131976","journal-title":"Lancet"},{"key":"6_CR77","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1399-0004.2011.01703.x","volume":"81","author":"L Faivre","year":"2011","unstructured":"Faivre L, Collod-Beroud G, Ades L, Arbustini E, Child A, Callewaert B, Loeys B, Binquet C, Gautier E, Mayer K, Arslan-Kirchner M, Grasso M, Beroud C, Hamroun D, Bonithon-Kopp C, Plauchu H, Robinson P, De Backer J, Coucke P, Francke U, Bouchot O, Wolf J, Stheneur C, Hanna N, Detaint D, De Paepe A, Boileau C, Jondeau G (2011) The new Ghent criteria for Marfan syndrome: what do they change? Clin Genet 81:433\u2013442","journal-title":"Clin Genet"},{"issue":"3","key":"6_CR78","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1399-0004.2011.01771.x","volume":"82","author":"S Sheikhzadeh","year":"2011","unstructured":"Sheikhzadeh S, Kade C, Keyser B, Stuhrmann M, Arslan-Kirchner M, Rybczynski M, Bernhardt A, Habermann C, Hillebrand M, Mir T, Robinson P, Berger J, Detter C, Blankenberg S, Schmidtke J, von Kodolitsch Y (2011) Analysis of phenotype and genotype information for the diagnosis of Marfan syndrome. Clin Genet 82(3):240\u2013247","journal-title":"Clin Genet"},{"key":"6_CR79","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1161\/01.CIR.0000128363.85581.E1","volume":"109","author":"BJ Maron","year":"2004","unstructured":"Maron BJ, Chaitman BR, Ackerman MJ, Bayes de Luna A, Corrado D, Crosson JE, Deal BJ, Driscoll DJ, 3rd Estes NA, Araujo CG, Liang DH, Mitten MJ, Myerburg RJ, Pelliccia A, Thompson PD, Towbin JA, Van Camp SP (2004) Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation 109:2807\u20132816","journal-title":"Circulation"},{"key":"6_CR80","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ijcard.2005.11.116","volume":"114","author":"DR Gersony","year":"2007","unstructured":"Gersony DR, McClaughlin MA, Jin Z, Gersony WM (2007) The effect of \u03b2-blocker therapy on clinical outcome in patients with Marfan's syndrome: a meta-analysis. Int J Cardiol 114:303\u2013308","journal-title":"Int J Cardiol"},{"key":"6_CR81","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.amjcard.2006.08.048","volume":"99","author":"M Ladouceur","year":"2007","unstructured":"Ladouceur M, Fermanian C, Lupoglazoff JM, Edouard T, Dulac Y, Acar P, Magnier S, Jondeau G (2007) Effect of \u03b2-blockade on ascending aortic dilatation in children with the Marfan syndrome. Am J Cardiol 99:406\u2013409","journal-title":"Am J Cardiol"},{"key":"6_CR82","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/0002-9149(94)90762-5","volume":"74","author":"MA Salim","year":"1994","unstructured":"Salim MA, Alpert BS, Ward JC, Pyeritz RE (1994) Effect of \u03b2-adrenergic blockade on aortic root rate of dilation in the Marfan syndrome. Am J Cardiol 74:629\u2013633","journal-title":"Am J Cardiol"},{"key":"6_CR83","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jpeds.2006.09.003","volume":"150","author":"ES Selamet Tierney","year":"2007","unstructured":"Selamet Tierney ES, Feingold B, Printz BF, Park SC, Graham D, Kleinman CS, Mahnke CB, Timchak DM, Neches WH, Gersony WM (2007) \u03b2-blocker therapy does not alter the rate of aortic root dilation in pediatric patients with Marfan syndrome. J Pediatr 150:77\u201382","journal-title":"J Pediatr"},{"key":"6_CR84","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/S0002-9149(99)00101-0","volume":"83","author":"R Rossi-Foulkes","year":"1999","unstructured":"Rossi-Foulkes R, Roman MJ, Rosen SE, Kramer-Fox R, Ehlers KH, O\u2019Loughlin JE, Davis JG, Devereux RB (1999) Phenotypic features and impact of \u03b2 blocker or calcium antagonist therapy on aortic lumen size in the Marfan syndrome. Am J Cardiol 83:1364\u20131368","journal-title":"Am J Cardiol"},{"issue":"8","key":"6_CR85","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/j.1365-2362.2012.02668.x","volume":"42","author":"A Williams","year":"2012","unstructured":"Williams A, Kenny D, Wilson D, Fagenello G, Nelson M, Dunstan F, Cockcroft J, Stuart G, Fraser AG (2012) Effects of atenolol, perindopril and verapamil on haemodynamic and vascular function in Marfan syndrome \u2013 a randomised, double-blind, crossover trial. Eur J Clin Invest 42(8):891\u2013899","journal-title":"Eur J Clin Invest"},{"key":"6_CR86","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1161\/CIRCULATIONAHA.106.183095","volume":"116","author":"W Wilson","year":"2007","unstructured":"Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, Bolger A, Cabell CH, Takahashi M, Baltimore RS, Newburger JW, Strom BL, Tani LY, Gerber M, Bonow RO, Pallasch T, Shulman ST, Rowley AH, Burns JC, Ferrieri P, Gardner T, Goff D, Durack DT (2007) Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 116:1736\u20131754","journal-title":"Circulation"},{"key":"6_CR87","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1056\/NEJMoa0706585","volume":"358","author":"BS Brooke","year":"2008","unstructured":"Brooke BS, Habashi JP, Judge DP, Patel N, Loeys B, Dietz HC 3rd (2008) Angiotensin II blockade and aortic-root dilation in Marfan\u2019s syndrome. N Engl J Med 358:2787\u20132795","journal-title":"N Engl J Med"},{"key":"6_CR88","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ahj.2007.06.024","volume":"154","author":"RV Lacro","year":"2007","unstructured":"Lacro RV, Dietz HC, Wruck LM, Bradley TJ, Colan SD, Devereux RB, Klein GL, Li JS, Minich LL, Paridon SM, Pearson GD, Printz BF, Pyeritz RE, Radojewski E, Roman MJ, Saul JP, Stylianou MP, Mahony L (2007) Rationale and design of a randomized clinical trial of \u03b2-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome. Am Heart J 154:624\u2013631","journal-title":"Am Heart J"},{"key":"6_CR89","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2459\/JCM.0b013e3283232a45","volume":"10","author":"FI Gambarin","year":"2009","unstructured":"Gambarin FI, Favalli V, Serio A, Regazzi M, Pasotti M, Klersy C, Dore R, Mannarino S, Vigano M, Odero A, Amato S, Tavazzi L, Arbustini E (2009) Rationale and design of a trial evaluating the effects of losartan vs. nebivolol vs. the association of both on the progression of aortic root dilation in Marfan syndrome with FBN1 gene mutations. J Cardiovasc Med 10:354\u2013362","journal-title":"J Cardiovasc Med"},{"key":"6_CR90","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.acvd.2010.04.008","volume":"103","author":"D Detaint","year":"2010","unstructured":"Detaint D, Aegerter P, Tubach F, Hoffman I, Plauchu H, Dulac Y, Faivre LO, Delrue MA, Collignon P, Odent S, Tchitchinadze M, Bouffard C, Arnoult F, Gautier M, Boileau C, Jondeau G (2010) Rationale and design of a randomized clinical trial (Marfan Sartan) of angiotensin II receptor blocker therapy versus placebo in individuals with Marfan syndrome. Arch Cardiovasc Dis 103:317\u2013325","journal-title":"Arch Cardiovasc Dis"},{"key":"6_CR91","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1745-6215-11-3","volume":"11","author":"T Radonic","year":"2010","unstructured":"Radonic T, de Witte P, Baars MJ, Zwinderman AH, Mulder BJ, Groenink M (2010) Losartan therapy in adults with Marfan syndrome: study protocol of the multi-center randomized controlled COMPARE trial. Trials 11:3","journal-title":"Trials"},{"key":"6_CR92","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.amjcard.2005.01.032","volume":"95","author":"AT Yetman","year":"2005","unstructured":"Yetman AT, Bornemeier RA, McCrindle BW (2005) Usefulness of enalapril versus propranolol or atenolol for prevention of aortic dilation in patients with the Marfan syndrome. Am J Cardiol 95:1125\u20131127","journal-title":"Am J Cardiol"},{"key":"6_CR93","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/ng1097-218","volume":"17","author":"L Pereira","year":"1997","unstructured":"Pereira L, Konstantinos A, Tian J, Lee SY, Keene DR, Ono R, Reinhardt DP, Sakai LY, Jensen-Biery N, Bunton T, Dietz HC, Ramirez F (1997) Targeting of the gene coding fibrillin-1 recapitulates the vascular phenotype of Marfan syndrome in the mouse. Nat Genet 17:218\u2013222","journal-title":"Nat Genet"},{"key":"6_CR94","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1161\/01.RES.88.1.37","volume":"88","author":"TE Bunton","year":"2001","unstructured":"Bunton TE, Biery NJ, Gayraud B, Ramirez F, Dietz HC (2001) Phenotypic modulation of vascular smooth muscle cells contributes to elastolysis in a mouse model of Marfan syndrome. Circ Res 88:37\u201343","journal-title":"Circ Res"},{"key":"6_CR95","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jvs.2007.09.016","volume":"47","author":"W Xiong","year":"2008","unstructured":"Xiong W, Knispel R, Dietz HC, Ramirez F, Baxter B (2008) T. Doxycycline delays aneurysm rupture in a mouse model of Marfan syndrome. J Vasc Surg 47:166\u2013172","journal-title":"J Vasc Surg"},{"key":"6_CR96","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1161\/CIRCRESAHA.108.174367","volume":"102","author":"A Chung","year":"2008","unstructured":"Chung A, Yang HHC, Radomski MW, van Breemen C (2008) Long-Term doxycycline is more effective than Atenolol to prevent thoracic aortic aneurysm in Marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9. Circ Res 102:e73\u2013e85","journal-title":"Circ Res"},{"key":"6_CR97","doi-asserted-by":"crossref","first-page":"S168","DOI":"10.1161\/CIRCULATIONAHA.110.012187","volume":"124","author":"D McLoughlin","year":"2011","unstructured":"McLoughlin D, McGuinness J, Byrne J, Terzo E, Huuskonen V, McAllister H, Black A, Kearney S, Kay E, Hill AD, Dietz HC, Redmond JM (2011) Pravastatin reduces Marfan aortic dilation. Circulation 124:S168\u2013S173","journal-title":"Circulation"},{"key":"6_CR98","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1161\/CIRCRESAHA.112.268268","volume":"110","author":"W Xiong","year":"2012","unstructured":"Xiong W, Meisinger T, Knispel R, Worth JM, Baxter BT (2012) MMP-2 regulates Erk1\/2 phosphorylation and aortic dilatation in Marfan syndrome. Circ Res 110:e92\u2013e101","journal-title":"Circ Res"},{"key":"6_CR99","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.yjmcc.2005.11.009","volume":"40","author":"P Booms","year":"2006","unstructured":"Booms P, Ney A, Barthel F, Moroy G, Counsell D, Gille C, Guo G, Pregla R, Mundlos S, Alix AJ, Robinson PN (2006) A fibrillin-1-fragment containing the elastin-binding-protein GxxPG consensus sequence upregulates matrix metalloproteinase-1: biochemical and computational analysis. J Mol Cell Cardiol 40:234\u2013246","journal-title":"J Mol Cell Cardiol"},{"key":"6_CR100","doi-asserted-by":"crossref","first-page":"e32963","DOI":"10.1371\/journal.pone.0032963","volume":"7","author":"T Radonic","year":"2012","unstructured":"Radonic T, de Witte P, Groenink M, de Waard V, Lutter R, van Eijk M, Jansen M, Timmermans J, Kempers M, Scholte AJ, Hilhorst-Hofstee Y, van den Berg MP, van Tintelen JP, Pals G, Baars MJ, Mulder BJ, Zwinderman AH (2012) Inflammation aggravates disease severity in Marfan syndrome patients. PLoS One 7:e32963","journal-title":"PLoS One"},{"key":"6_CR101","first-page":"II331","volume":"98","author":"AM Segura","year":"1998","unstructured":"Segura AM, Luna RE, Horiba K, Stetler-Stevenson WG, McAllister HA Jr, Willerson JT, Ferrans VJ (1998) Immunohistochemistry of matrix metalloproteinases and their inhibitors in thoracic aortic aneurysms and aortic valves of patients with Marfan\u2019s syndrome. Circulation 98:II331\u2013II338","journal-title":"Circulation"},{"key":"6_CR102","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1161\/CIRCULATIONAHA.108.806505","volume":"119","author":"JH Lindeman","year":"2009","unstructured":"Lindeman JH, Abdul-Hussien H, van Bockel JH, Wolterbeek R, Kleemann R (2009) Clinical trial of doxycycline for matrix metalloproteinase-9 inhibition in patients with an abdominal aneurysm: doxycycline selectively depletes aortic wall neutrophils and cytotoxic T cells. Circulation 119:2209\u20132216","journal-title":"Circulation"},{"key":"6_CR103","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jvs.2008.09.055","volume":"49","author":"H Abdul-Hussien","year":"2009","unstructured":"Abdul-Hussien H, Hanemaaijer R, Verheijen JH, van Bockel JH, Geelkerken RH, Lindeman JH (2009) Doxycycline therapy for abdominal aneurysm: improved proteolytic balance through reduced neutrophil content. J Vasc Surg 49:741\u2013749","journal-title":"J Vasc Surg"},{"key":"6_CR104","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/nrcardio.2010.31","volume":"7","author":"V Canadas","year":"2010","unstructured":"Canadas V, Vilacosta I, Bruna I, Fuster V (2010) Marfan syndrome. Part 2: treatment and management of patients. Nat Rev Cardiol 7:266\u2013276","journal-title":"Nat Rev Cardiol"},{"key":"6_CR105","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/j.athoracsur.2008.01.032","volume":"85","author":"ND Patel","year":"2008","unstructured":"Patel ND, Weiss ES, Alejo DE, Nwakanma LU, Williams JA, Dietz HC, Spevak PJ, Gott VL, Vricella LA, Cameron DE (2008) Aortic root operations for Marfan syndrome: a comparison of the Bentall and valve-sparing procedures. Ann Thorac Surg 85:2003\u20132011","journal-title":"Ann Thorac Surg"},{"key":"6_CR106","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jtcvs.2008.11.030","volume":"137","author":"IV Volguina","year":"2009","unstructured":"Volguina IV, Miller DC, Lemaire SA, Palmero LC, Wang XL, Connolly HM, Sundt TM 3rd, Bavaria JE, Dietz HC, Milewicz DM, Coselli JS (2009) Valve-sparing and valve-replacing techniques for aortic root replacement in patients with Marfan syndrome: analysis of early outcome. J Thorac Cardiovasc Surg 137:641\u2013649","journal-title":"J Thorac Cardiovasc Surg"},{"key":"6_CR107","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00441-009-0822-x","volume":"339","author":"F Ramirez","year":"2009","unstructured":"Ramirez F, Sakai LY (2009) Biogenesis and function of fibrillin assemblies. Cell Tissue Res 339:71\u201382","journal-title":"Cell Tissue Res"},{"key":"6_CR108","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1086\/520125","volume":"81","author":"L Faivre","year":"2007","unstructured":"Faivre L, Collod-Beroud G, Loeys BL, Child A, Binquet C, Gautier E, Callewaert B, Arbustini E, Mayer K, Arslan-Kirchner M, Kiotsekoglou A, Comeglio P, Marziliano N, Dietz HC, Halliday D, Beroud C, Bonithon-Kopp C, Claustres M, Muti C, Plauchu H, Robinson PN, Ades LC, Biggin A, Benetts B, Brett M, Holman KJ, De Backer J, Coucke P, Francke U, De Paepe A, Jondeau G, Boileau C (2007) Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. Am J Hum Genet 81:454\u2013466","journal-title":"Am J Hum Genet"},{"key":"6_CR109","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ceb.2009.05.005","volume":"21","author":"F Ramirez","year":"2009","unstructured":"Ramirez F, Rifkin DB (2009) Extracellular microfibrils: contextual platforms for TGF\u03b2 and BMP signaling. Curr Opin Cell Biol 21:616\u2013622","journal-title":"Curr Opin Cell Biol"},{"key":"6_CR110","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/sj.ejhg.5200582","volume":"9","author":"F Tiecke","year":"2001","unstructured":"Tiecke F, Katzke S, Booms P, Robinson PN, Neumann L, Godfrey M, Mathews KR, Scheuner M, Hinkel GK, Brenner RE, Hovels-Gurich HH, Hagemeier C, Fuchs J, Skovby F, Rosenberg T (2001) Classic, atypically severe and neonatal Marfan syndrome: twelve mutations and genotype-phenotype correlations in FBN1 exons 24-40. Eur J Hum Genet 9:13\u201321","journal-title":"Eur J Hum Genet"},{"key":"6_CR111","doi-asserted-by":"crossref","first-page":"23ra20","DOI":"10.1126\/scitranslmed.3000488","volume":"2","author":"BL Loeys","year":"2010","unstructured":"Loeys BL, Gerber EE, Riegert-Johnson D, Iqbal S, Whiteman P, McConnell V, Chillakuri CR, Macaya D, Coucke PJ, De Paepe A, Judge DP, Wigley F, Davis EC, Mardon HJ, Handford P, Keene DR, Sakai LY, Dietz HC (2010) Mutations in fibrillin-1 cause congenital scleroderma: stiff skin syndrome. Sci Transl Med 2:23ra20","journal-title":"Sci Transl Med"},{"key":"6_CR112","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/jmg.40.1.34","volume":"40","author":"L Faivre","year":"2003","unstructured":"Faivre L, Gorlin RJ, Wirtz MK, Godfrey M, Dagoneau N, Samples JR, Le Merrer M, Collod-Beroud G, Boileau C, Munnich A, Cormier-Daire V (2003) In frame fibrillin-1 gene deletion in autosomal dominant Weill-Marchesani syndrome. J Med Genet 40:34\u201336","journal-title":"J Med Genet"},{"key":"6_CR113","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ajhg.2011.05.012","volume":"89","author":"C Le Goff","year":"2011","unstructured":"Le Goff C, Mahaut C, Wang LW, Allali S, Abhyankar A, Jensen S, Zylberberg L, Collod-Beroud G, Bonnet D, Alanay Y, Brady AF, Cordier MP, Devriendt K, Genevieve D, Kiper PO, Kitoh H, Krakow D, Lynch SA, Le Merrer M, Megarbane A, Mortier G, Odent S, Polak M, Rohrbach M, Sillence D, Stolte-Dijkstra I, Superti-Furga A, Rimoin DL, Topouchian V, Unger S, Zabel B, Bole-Feysot C, Nitschke P, Handford P, Casanova JL, Boileau C, Apte SS, Munnich A, Cormier-Daire V (2011) Mutations in the TGF\u03b2 binding-protein-like domain 5 of FBN1 are responsible for acromicric and geleophysic dysplasias. Am J Hum Genet 89:7\u201314","journal-title":"Am J Hum Genet"},{"key":"6_CR114","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/ng0296-209","volume":"12","author":"S Sood","year":"1996","unstructured":"Sood S, Eldadah ZA, Krause WL, McIntosh I, Dietz HC (1996) Mutation in fibrillin-1 and the Marfanoid-craniosynostosis (Shprintzen-Goldberg) syndrome. Nat Genet 12:209\u2013211","journal-title":"Nat Genet"},{"key":"6_CR115","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1152\/physiolgenomics.00092.2004","volume":"19","author":"F Ramirez","year":"2004","unstructured":"Ramirez F, Sakai LY, Dietz HC, Rifkin DB (2004) Fibrillin microfibrils: multipurpose extracellular networks in organismal physiology. Physiol Genomics 19:151\u2013154","journal-title":"Physiol Genomics"},{"key":"6_CR116","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1056\/NEJM199007193230303","volume":"323","author":"DW Hollister","year":"1990","unstructured":"Hollister DW, Godfrey M, Sakai LY, Pyeritz RE (1990) Immunohistologic abnormalities of the microfibrillar-fiber system in the Marfan syndrome. N Engl J Med 323:152\u2013159","journal-title":"N Engl J Med"},{"key":"6_CR117","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.1074\/jbc.M806962200","volume":"284","author":"L Carta","year":"2009","unstructured":"Carta L, Smaldone S, Zilberberg L, Loch D, Dietz HC, Rifkin DB, Ramirez F (2009) p38 MAPK is an early determinant of promiscuous Smad2\/3 signaling in the aortas of fibrillin-1 (Fbn1)-null mice. J Biol Chem 284:5630\u20135636","journal-title":"J Biol Chem"},{"key":"6_CR118","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1126\/science.1124287","volume":"312","author":"JP Habashi","year":"2006","unstructured":"Habashi JP, Judge D, Holm TM, Cohn RD, Loeys BL, Cooper TK, Myers L, Klein EC, Liu G, Calvi C, Podowski M, Neptune ER, Halushka MK, Bedja D, Garielson K, Rifkin DB, Carta L, Ramirez F, Huso DL, Dietz HC (2006) Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312:117\u2013121","journal-title":"Science"},{"key":"6_CR119","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng1116","volume":"33","author":"ER Neptune","year":"2003","unstructured":"Neptune ER, Frischmeyer PA, Arking DE, Myers L, Bunton TE, Gayraud B, Ramirez F, Sakai LY, Dietz HC (2003) Dysregulation of TGF\u03b2 activation contributes to pathogenesis in Marfan syndrome. Nat Genet 33:407\u2013411","journal-title":"Nat Genet"},{"key":"6_CR120","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1074\/jbc.M209256200","volume":"278","author":"Z Isogai","year":"2003","unstructured":"Isogai Z, Ono RN, Ushiro S, Keene DR, Chen Y, Mazzieri R, Charbonneau NL, Reinhardt DP, Rifkin DB, Sakai LY (2003) Latent transforming growth factor -binding protein 1 interacts with fibrillin and is a microfibril-associated protein. J Biol Chem 278:2750\u20132757","journal-title":"J Biol Chem"},{"key":"6_CR121","doi-asserted-by":"crossref","first-page":"13874","DOI":"10.1074\/jbc.M707820200","volume":"283","author":"G Sengle","year":"2008","unstructured":"Sengle G, Charbonneau NL, Ono RN, Sasaki T, Alvarez J, Keene DR, Bachinger HP, Sakai LY (2008) Targeting of bone morphogenetic protein growth factor complexes to fibrillin. J Biol Chem 283:13874\u201313888","journal-title":"J Biol Chem"},{"key":"6_CR122","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1073\/pnas.96.7.3819","volume":"96","author":"L Pereira","year":"1999","unstructured":"Pereira L, Lee SY, Gayraud B, Andrikopoulos K, Shapiro SD, Bunton T, Jensen Biery N, Dietz HC, Sakai LY, Ramirez F (1999) Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1. Proc Natl Acad Sci U S A 96:3819\u20133823","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6_CR123","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1093\/hmg\/ddq409","volume":"19","author":"H Nistala","year":"2010","unstructured":"Nistala H, Lee-Arteaga S, Carta L, Cook JR, Smaldone S, Siciliano G, Rifkin AN, Dietz HC, Rifkin DB, Ramirez F (2010) Differential effects of alendronate and losartan therapy on osteopenia and aortic aneurysm in mice with severe Marfan syndrome. Hum Mol Genet 19:4790\u20134798","journal-title":"Hum Mol Genet"},{"key":"6_CR124","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1172\/JCI200420641","volume":"114","author":"DP Judge","year":"2004","unstructured":"Judge DP, Biery N, Keene DR, Geubtner J, Myers L, Huso DL, Sakai LY, Dietz HC (2004) Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome. J Clin Invest 114:172\u2013181","journal-title":"J Clin Invest"},{"key":"6_CR125","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1161\/01.CIR.103.6.789","volume":"103","author":"D-S Lim","year":"2001","unstructured":"Lim D-S, Lutucuta S, Bachireddy P, Youker K, Evans A, Entman M, Roberts R, Marian AJ (2001) Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy. Circulation 103:789\u2013791","journal-title":"Circulation"},{"key":"6_CR126","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1097\/01.hjh.0000182521.44440.c5","volume":"23","author":"P Lavoie","year":"2005","unstructured":"Lavoie P, Robitaille G, Agharazii M, Ledbetter S, Lebel M, Lariviere R (2005) Neutralization of transforming growth factor-\u03b2 attenuates hypertension and prevents renal injury in uremic rats. J Hypertens 23:1895\u20131903","journal-title":"J Hypertens"},{"key":"6_CR127","doi-asserted-by":"crossref","first-page":"F278","DOI":"10.1152\/ajprenal.00139.2003","volume":"286","author":"T Naito","year":"2004","unstructured":"Naito T, Masaki T, Nikolic-Paterson DJ, Tanji C, Yorioka N, Kohno N (2004) Angiotensin II induces thrombospondin-1 production in human mesangial cells via p38 MAPK and JNK: a mechanism for activation of latent TGF-\u03b21. Am J Physiol Renal Physiol 286:F278\u2013F287","journal-title":"Am J Physiol Renal Physiol"},{"key":"6_CR128","doi-asserted-by":"crossref","first-page":"8016","DOI":"10.1074\/jbc.M511599200","volume":"281","author":"L Carta","year":"2006","unstructured":"Carta L, Pereira L, Arteaga-Solis E, Lee-Arteaga SY, Lenart B, Starcher B, Merkel CA, Sukoyan M, Kerkis A, Hazeki N, Keene DR, Sakai LY, Ramirez F (2006) Fibrillins 1 and 2 perform partially overlapping functions during aortic development. J Biol Chem 281:8016\u20138023","journal-title":"J Biol Chem"},{"key":"6_CR129","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1126\/science.1192152","volume":"332","author":"JP Habashi","year":"2011","unstructured":"Habashi JP, Doyle JJ, Holm TM, Aziz H, Schoenhoff F, Bedja D, Chen Y, Modiri AN, Judge DP, Dietz HC (2011) Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism. Science 332:361\u2013365","journal-title":"Science"},{"key":"6_CR130","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1126\/science.1192149","volume":"332","author":"TM Holm","year":"2011","unstructured":"Holm TM, Habashi JP, Doyle JJ, Bedja D, Chen Y, van Erp C, Lindsay ME, Kim D, Schoenhoff F, Cohn RD, Loeys BL, Thomas CJ, Patnaik S, Marugan JJ, Judge DP, Dietz HC (2011) Noncanonical TGF\u03b2 signaling contributes to aortic aneurysm progression in Marfan syndrome mice. Science 332:358\u2013361","journal-title":"Science"},{"key":"6_CR131","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/msj.20200","volume":"77","author":"JR Cook","year":"2010","unstructured":"Cook JR, Nistala H, Ramirez F (2010) Drug-based therapies for vascular disease in Marfan syndrome: from mouse models to human patients. Mt Sinai J Med 77:366\u2013373","journal-title":"Mt Sinai J Med"},{"key":"6_CR132","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1083\/jcb.201003089","volume":"190","author":"H Nistala","year":"2010","unstructured":"Nistala H, Lee-Arteaga S, Smaldone S, Siciliano G, Carta L, Ono RN, Sengle G, Arteaga-Solis E, Levasseur R, Ducy P, Sakai LY, Karsenty G, Ramirez F (2010) Fibrillin-1 and -2 differentially modulate endogenous TGF\u03b2 and BMP bioavailability during bone formation. J Cell Biol 190:1107\u20131121","journal-title":"J Cell Biol"},{"key":"6_CR133","first-page":"667","volume-title":"The TGF\u03b2 family","author":"T Alliston","year":"2008","unstructured":"Alliston T, Piek E, Derynck R (2008) TGF\u03b2 family signaling in skeletal development, maintenance and disease. In: Derynck R, Miyazono K (eds) The TGF\u03b2 family. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, pp 667\u2013723"},{"key":"6_CR134","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1210\/er.2004-0001","volume":"26","author":"K Janssens","year":"2005","unstructured":"Janssens K, ten Dijke P, Janssens S, Van Hul W (2005) Transforming growth factor-\u03b21 to the bone. Endocr Rev 26:743\u2013774","journal-title":"Endocr Rev"},{"issue":"8","key":"6_CR135","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/dvg.22022","volume":"50","author":"JR Cook","year":"2012","unstructured":"Cook JR, Smaldone S, Cozzolino C, Del Solar M, Lee-Arteaga S, Nistala H, Ramirez F (2012) Generation of Fbn1 conditional null mice implicates the extracellular microfibrils in osteoprogenitor recruitment. Genesis 50(8):635\u2013641","journal-title":"Genesis"},{"key":"6_CR136","first-page":"283","volume":"19","author":"A Gigante","year":"1999","unstructured":"Gigante A, Chillemi C, Greco F (1999) Changes of elastic fibers in musculoskeletal tissues of Marfan syndrome: a possible mechanism of joint laxity and skeletal overgrowth. J Pediatr Orthop 19:283\u2013288","journal-title":"J Pediatr Orthop"},{"key":"6_CR137","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1196\/annals.1402.059","volume":"1116","author":"HM Kronenberg","year":"2007","unstructured":"Kronenberg HM (2007) The role of the perichondrium in fetal bone development. Ann N Y Acad Sci 1116:59\u201364","journal-title":"Ann N Y Acad Sci"}],"container-title":["Advances in Experimental Medicine and Biology","Progress in Heritable Soft Connective Tissue Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-94-007-7893-1_6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T22:51:45Z","timestamp":1675119105000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-94-007-7893-1_6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,14]]},"ISBN":["9789400778924","9789400778931"],"references-count":137,"URL":"https:\/\/doi.org\/10.1007\/978-94-007-7893-1_6","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2013,12,14]]},"assertion":[{"value":"14 December 2013","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}